Drug General Information
Drug ID
D0J5LJ
Former ID
DNC001318
Drug Name
Selenocompounds
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535350]
Structure
Download
2D MOL
Formula
C14H19N5O5
Canonical SMILES
C1COCC1NC2=NC=NC3=C2N=CN3C4C(C(C(O4)CO)O)O
InChI
1S/C14H19N5O5/c20-3-8-10(21)11(22)14(24-8)19-6-17-9-12(15-5-16-13(9)19)18-7-1-2-23-4-7/h5-8,10-11,14,20-22H,1-4H2,(H,15,16,18)/t7-,8-,10-,11-,14-/m1/s1
InChIKey
OESBDSFYJMDRJY-BAYCTPFLSA-N
CAS Number
CAS 204512-90-3
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Protein kinase C Target Info Binder [535350]
References
Ref 535350Protein kinase C as a molecular target for cancer prevention by selenocompounds. Nutr Cancer. 2001;40(1):55-63.
Ref 535350Protein kinase C as a molecular target for cancer prevention by selenocompounds. Nutr Cancer. 2001;40(1):55-63.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.